TELITHROMYCIN: 73 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
73
Total FAERS Reports
12 (16.4%)
Deaths Reported
14
Hospitalizations
73
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
Apr 1, 2004
FDA Approved
Discontinued
Status
FDA Application: 021144 ·
First Report: 2003 · Latest Report: 20161017
What Are the Most Common TELITHROMYCIN Side Effects?
#1 Most Reported
Drug hypersensitivity
20 reports (27.4%)
#2 Most Reported
Hypersensitivity
9 reports (12.3%)
#3 Most Reported
Therapeutic response decreased
8 reports (11.0%)
All TELITHROMYCIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 20 | 27.4% | 0 | 1 |
| Hypersensitivity | 9 | 12.3% | 0 | 0 |
| Drug resistance | 8 | 11.0% | 8 | 0 |
| Therapeutic response decreased | 8 | 11.0% | 8 | 0 |
| Back pain | 5 | 6.9% | 0 | 1 |
| Myalgia | 5 | 6.9% | 0 | 0 |
Who Reports TELITHROMYCIN Side Effects? Age & Gender Data
Gender: 64.3% female, 35.7% male. Average age: 56.8 years. Most reports from: US. View detailed demographics →
Is TELITHROMYCIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 2 | 0 | 0 |
| 2006 | 3 | 0 | 3 |
| 2007 | 1 | 0 | 0 |
| 2009 | 1 | 0 | 0 |
| 2010 | 2 | 0 | 1 |
| 2012 | 4 | 0 | 0 |
| 2014 | 2 | 1 | 1 |
| 2015 | 7 | 2 | 4 |
| 2016 | 2 | 0 | 1 |
What Is TELITHROMYCIN Used For?
| Indication | Reports |
|---|---|
| Bronchitis | 12 |
| Infective pulmonary exacerbation of cystic fibrosis | 6 |
| Product used for unknown indication | 6 |
Official FDA Label for TELITHROMYCIN
Official prescribing information from the FDA-approved drug label.